Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioncarbohydrate binding

CLEC1A FCN2

8.05e-0331092GO:0030246
MousePhenoincreased angiogenesis

CRHR2 CD82

8.67e-052972MP:0005601
MousePhenoincreased susceptibility to bacterial infection

PIGR CD82 FCN2

2.71e-0428373MP:0002412
MousePhenoabnormal susceptibility to bacterial infection

PIGR CD82 FCN2

5.49e-0436073MP:0020186
MousePhenoincreased susceptibility to infection

PIGR CD82 FCN2

1.46e-0350473MP:0002406
Pubmed

A High-Density Map for Navigating the Human Polycomb Complexome.

ZMYM3 PIGR ZNF678

2.26e-044959327705803
InteractionZNF202 interactions

ZMYM3 PIGR

8.73e-053292int:ZNF202
InteractionFCN1 interactions

PIGR FCN2

9.29e-053392int:FCN1
CoexpressionGSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN

ZBTB11 PIGR CD82

3.55e-0520093M6989
ToppCell367C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

CLEC1A PIGR

4.23e-04156920b3630fd4479291599e1674e87eba6f93877ac3a
ToppCell10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_memory|bone_marrow / Manually curated celltypes from each tissue

PIGR CD82

4.68e-0416492746833f74095c0f25ce76baf1069f1848c231933
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

PIGR CD82

4.96e-0416992e3ec9468141b6456398dca17dd8eeaabd2462710
ToppCellfacs-Diaphragm-Limb_Muscle-18m-Endothelial-new-cluster|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC1A PIGR

5.02e-04170924fb4ce46e4fa2418238e264875209d7ebe844d82
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CLEC1A FCN2

5.14e-0417292c056d44e2e130ceccadfcdceb192a7f095d779c8
ToppCellfacs-Diaphragm-Limb_Muscle-18m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC1A PIGR

5.20e-04173926a7e4fa2d9d00f50decc89b535d8a68ec96de58a
ToppCellfacs-Mammary_Gland-Mammary_Gland-18m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC1A CRHR2

5.20e-04173920b79e2a4fd19d524c24b69a6b524ffc6affdabe5
ToppCellfacs-Mammary_Gland-Mammary_Gland-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC1A CRHR2

5.20e-0417392a2c1ef3f4d7e9f68fc77ee7c42a4727bdea5da94
ToppCellfacs-Mammary_Gland-Mammary_Gland-18m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC1A CRHR2

5.20e-04173924830136f1f1976e00ac9af9062a531ac42533041
ToppCellfacs-Diaphragm-Limb_Muscle-18m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC1A PIGR

5.20e-04173922a5ea28c65dd4ee03ba3d0bfe0c819b1d583f8da
ToppCell(03)_Secretory-(0)_uninjured|(03)_Secretory / shred by cell type and Timepoint

PIGR CD82

5.26e-0417492ebdddb5091afcc49ab533c890f260f709880c5f9
ToppCellPND07-Epithelial-Epithelial_Airway-Neurosecretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CRHR2 PIGR

5.32e-041759219eda8b5d39dc93d79737ebdbeeba5ec0cb23c51
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PIGR CD82

5.50e-0417892be1d991c5a0a5be22f14f57d34ee1330f1a12963
ToppCellLeuk-UTI-Lymphocyte-B-B_intermediate|Leuk-UTI / Disease, Lineage and Cell Type

PIGR CD82

5.56e-041799201933f6fa94d7032ed403a6cae6985cafa820043
ToppCell390C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

ZMYM3 ZNF678

5.56e-04179923edcd1356e49b1f5514c585861999e079ca5e579
ToppCell390C-Lymphocytic-ILC-ILC-1|390C / Donor, Lineage, Cell class and subclass (all cells)

ZMYM3 ZNF678

5.56e-0417992e7045e27f0eb88f552b31c04b56d78e5ccd7a36c
ToppCellAT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

PIGR FCN2

5.69e-0418192ed0ea67f0607073aedf153f8d1073b35e46127c3
ToppCellfacs-Heart-LA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PIGR CD82

5.75e-041829247b747722766dbcc6a73673e99ee5f938b82b890
ToppCell3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CLEC1A FCN2

5.94e-0418592a987dbf6adf533c5f8a0a8a465a6c8e67e0ffcc8
ToppCellCOVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

CLEC1A FCN2

5.94e-0418592673308ca0514a4d3629d61fe91e9d8fb31b72166
ToppCell5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CLEC1A FCN2

6.00e-0418692e9d12f2fcd346fc8d00f7178324ea5997628df8a
ToppCellControl-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CLEC1A CD82

6.07e-0418792ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell21-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class

CLEC1A FCN2

6.26e-0419092bce09634acbc2cfd53666328e8aed8bf8835f845
ToppCell21-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class

CLEC1A FCN2

6.26e-041909208437396a98ca9526f69c3a74bbf2929f3c68b8e
ToppCell(09)_Interm._secr.>cil.-(0)_Reference|(09)_Interm._secr.>cil. / shred by cell type by condition

PIGR CD82

6.33e-0419192e63432718d62d39165ba8a66e14bb38c93907ffe
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PIGR CD82

6.33e-04191927235a4d1601c88a2c8af571a2c04ab56d32f1b9a
ToppCellIPF-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class

PIGR CD82

6.33e-0419192267e1192aaec468c1a59eb24848b37e0e18cbc44
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PIGR CD82

6.33e-04191920a0719a0a49ae0099d61e22585ac74c10c24b4a2
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PIGR CD82

6.39e-0419292967122c53af25b8f19a8411b4553d764c8d51c4d
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PIGR CD82

6.46e-0419392371f4c98a599923fbe8382530b3eab05d873665a
ToppCellCOPD-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class

PIGR CD82

6.53e-041949272a2e0cba171ab59aa176e91a59a54c562af0390
ToppCellHealthy-B_intermediate|Healthy / disease group, cell group and cell class

PIGR CD82

6.53e-0419492aabee48bf689367edae2079b4b90d253715f1097
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PIGR CD82

6.59e-0419592576142b4e75457c0973051bccc4163bd624496af
ToppCellCOVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type

CLEC1A FCN2

6.59e-0419592a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PIGR CD82

6.59e-04195928f151066ad3ebd9661ea0b733f03c2ce1518f9ad
ToppCellEpithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id

PIGR CD82

6.59e-0419592b758676abfc4e6930b696d270ecc0ea461b87a54
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PIGR CD82

6.59e-04195922a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464
ToppCellHealthy-B_intermediate|World / disease group, cell group and cell class

PIGR CD82

6.59e-04195929de79e0bdd9063ae65e5edb89cc3fe6f9a8173bc
ToppCell(05)_Secretory-(0)_Reference|(05)_Secretory / shred by cell type by condition

PIGR CD82

6.66e-04196927cb79cf122852c971f2d6e8d1e2b26eade891e83
ToppCellCOVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type

CLEC1A FCN2

6.66e-0419692b71b197cb92117dd9efaa13de000841901cc4ca8
ToppCell5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CLEC1A CD82

6.66e-0419692a53caedd0103bd162b3aee8ab87b4442a5e0338f
ToppCell(00)_Basal-(0)_Reference|(00)_Basal / shred by cell type by condition

PIGR CD82

6.66e-0419692ba03530a20d7b29902721fd50df8d860557ddefa
ToppCellCOVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class

PIGR CD82

6.73e-041979278ed2810e5a765327e7a6da0ca5d4854bf7a0b6f
ToppCellnormal_Lung-Epithelial_cells-Club|Epithelial_cells / Location, Cell class and cell subclass

PIGR CD82

6.80e-0419892a9d0109ca05eb3e9c588f9677ec471dd5c092a75
ToppCellParenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PIGR CD82

6.80e-0419892fab3135f03cf23a9f04f0eed543a9dc181f39f5f
ToppCellBronchial_Brush-Epithelial-Club|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X

PIGR CD82

6.80e-041989261292a2b5aacb6080a679a31b70a211bdec59a3b
ToppCellTracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

CLEC1A CD82

6.87e-04199921621ce2968f3100e4c39e0ef8293232a5d76c614
ToppCellBronchial_Brush-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

PIGR CD82

6.87e-041999253b87edccc89a3e8a6c5166472f9ef24fcba416c
ToppCellSepsis-Leuk-UTI-Lymphocyte-B-B_intermediate|Leuk-UTI / Disease, condition lineage and cell class

PIGR CD82

6.87e-0419992e3edf3bcb381dbcf0092bdc2ee93ba852d32af3f
ToppCellBronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X

PIGR CD82

6.87e-0419992ef5d8917c8d011184830a0b8197afc6266707b37
ToppCellBiopsy_IPF-Epithelial-MUC5B+|Biopsy_IPF / Sample group, Lineage and Cell type

PIGR CD82

6.93e-0420092f0a6747f6d37ec6d261bd649ac678c39cca5e4c8
ToppCellParenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PIGR CD82

6.93e-0420092b992eeddee38e6fe3564e9b1850f6b20b89bf47d
ToppCellSepsis-Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, condition lineage and cell class

PIGR CD82

6.93e-0420092221dd8d8851c47f2202ba848de3a041b17b1db3f
ComputationalNeighborhood of RBBP8

CRHR2 ZBTB11 PIGR

2.53e-0421373MORF_RBBP8
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

PIGR CD82

4.39e-045072GAVISH_3CA_MALIGNANT_METAPROGRAM_23_SECRETED_2
ComputationalMembranal receptors.

CRHR2 PIGR CD82

3.35e-0351773MODULE_64
ComputationalGenes in the cancer module 12.

CRHR2 PIGR CD82

3.39e-0351973MODULE_13
ComputationalNeighborhood of LTK

CRHR2 PIGR

3.73e-0314772MORF_LTK
ComputationalNeighborhood of RAGE

CRHR2 PIGR

3.78e-0314872MORF_RAGE
ComputationalGenes in the cancer module 41.

CRHR2 CD82 FCN2

4.33e-0356673MODULE_41
ComputationalNeighborhood of FANCG

CRHR2 PIGR

4.79e-0316772MORF_FANCG
DrugButylparaben [94-26-8]; Up 200; 20.6uM; MCF7; HT_HG-U133A

CRHR2 PIGR CD82

5.00e-05195935608_UP
DrugIdazoxan hydrochloride [79944-56-2]; Up 200; 16.6uM; MCF7; HT_HG-U133A

CRHR2 PIGR CD82

5.00e-05195936465_UP
DrugBetonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A

CRHR2 PIGR CD82

5.08e-05196933745_UP
DrugTropicamide [1508-75-4]; Up 200; 14uM; PC3; HT_HG-U133A

CLEC1A PIGR CD82

5.24e-05198933722_UP
DrugTiapride hydrochloride [51012-33-0]; Up 200; 11uM; MCF7; HT_HG-U133A

CRHR2 PIGR CD82

5.31e-05199932292_UP
Drugbutenal

CLEC1A CRHR2

2.16e-0318092CID000020138
DrugAlexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; PC3; HT_HG-U133A

CRHR2 PIGR

2.20e-03182923699_UP
DrugAzlocillin sodium salt [37091-65-9]; Up 200; 8.2uM; MCF7; HT_HG-U133A

CRHR2 CD82

2.40e-03190923468_UP
Drugresveratrol; Up 200; 50uM; PC3; HG-U133A

CRHR2 CD82

2.42e-0319192662_UP
DrugChlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; MCF7; HT_HG-U133A

CLEC1A CRHR2

2.42e-03191922627_UP
DrugAntipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; MCF7; HT_HG-U133A

CRHR2 PIGR

2.45e-03192924175_UP
DrugMegestrol acetate [595-33-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A

CRHR2 PIGR

2.45e-03192925013_UP
DrugCloperastine hydrochloride [14984-68-0]; Up 200; 11uM; MCF7; HT_HG-U133A

CD82 FCN2

2.47e-03193923608_UP
DrugDecamethonium bromide [541-22-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A

CLEC1A CRHR2

2.47e-03193924174_UP
DrugBenzocaine [94-09-7]; Up 200; 24.2uM; PC3; HT_HG-U133A

CRHR2 PIGR

2.50e-03194924224_UP
DrugAvermectin B1 [71751-41-2]; Down 200; 4.8uM; MCF7; HT_HG-U133A

ZMYM3 CD82

2.50e-03194926081_DN
DrugAcetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; HL60; HG-U133A

PIGR CD82

2.50e-03194921377_DN
DrugOrphenadrine hydrochloride [341-69-5]; Up 200; 13uM; PC3; HT_HG-U133A

CRHR2 PIGR

2.50e-03194924537_UP
DrugSalsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; PC3; HT_HG-U133A

CLEC1A CRHR2

2.53e-03195924232_UP
DrugLY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A

CRHR2 PIGR

2.53e-03195925576_UP
DrugOfloxacin [82419-36-1]; Up 200; 11uM; PC3; HT_HG-U133A

CLEC1A ZMYM3

2.53e-03195927372_UP
DrugTiclopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; MCF7; HT_HG-U133A

ZMYM3 CD82

2.53e-03195924155_DN
DrugCimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HT_HG-U133A

CLEC1A CRHR2

2.53e-03195924063_UP
DrugFurazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A

ZMYM3 CD82

2.53e-03195923358_DN
DrugNitrocaramiphen hydrochloride; Up 200; 10.8uM; MCF7; HT_HG-U133A

CRHR2 PIGR

2.55e-03196926504_UP
DrugIvermectin [70288-86-7]; Down 200; 4.6uM; HL60; HG-U133A

PIGR CD82

2.55e-03196921367_DN
DrugLomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A

CRHR2 CD82

2.55e-03196922310_UP
DrugRisperidone [106266-06-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A

CRHR2 CD82

2.55e-03196923508_UP
DrugGossypol [303-45-7]; Down 200; 7.8uM; PC3; HT_HG-U133A

ZMYM3 CD82

2.55e-03196924296_DN
Drug17-AAG; Down 200; 1uM; PC3; HG-U133A

PIGR CD82

2.55e-0319692432_DN
DrugChlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; HL60; HT_HG-U133A

ZMYM3 CD82

2.55e-03196921864_DN
Drugtetraethylenepentamine pentahydrochloride; Down 200; 100uM; HL60; HG-U133A

CLEC1A PIGR

2.55e-0319692412_DN
DrugDiperodon hydrochloride [537-12-2]; Down 200; 9.2uM; HL60; HG-U133A

ZMYM3 CD82

2.55e-03196921575_DN
DrugAminohippuric acid [61-78-9]; Up 200; 20.6uM; MCF7; HT_HG-U133A

CRHR2 CD82

2.55e-03196926453_UP
DrugChlorpropamide [94-20-2]; Up 200; 14.4uM; MCF7; HT_HG-U133A

PIGR CD82

2.55e-03196923210_UP
DrugPHA-00745360 [351320-33-7]; Up 200; 1uM; PC3; HT_HG-U133A

CRHR2 PIGR

2.55e-03196923827_UP
DrugEtilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A

PIGR CD82

2.55e-03196924415_UP
DrugFlecainide acetate [54143-56-5]; Up 200; 8.4uM; PC3; HT_HG-U133A

CRHR2 CD82

2.55e-03196923761_UP
DrugSulpiride [15676-16-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A

CRHR2 CD82

2.58e-03197921467_UP
DrugBumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A

ZMYM3 CD82

2.58e-03197927440_DN
DrugPentolinium bitartrate [52-62-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A

PIGR CD82

2.58e-03197922305_UP
DrugHymecromone [90-33-5]; Up 200; 22.8uM; HL60; HT_HG-U133A

CRHR2 PIGR

2.58e-03197923045_UP
DrugSuccinylsulfathiazole [116-43-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A

PIGR CD82

2.58e-03197922821_UP
Drugsulindac; Down 200; 100uM; MCF7; HG-U133A

PIGR CD82

2.58e-0319792168_DN
DrugAmoxapine [14028-44-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A

CRHR2 CD82

2.58e-03197921513_UP
DrugWY-14643; Up 200; 100uM; PC3; HG-U133A

CLEC1A PIGR

2.58e-0319792464_UP
DrugErythromycin [114-07-8]; Up 200; 5.4uM; PC3; HT_HG-U133A

CLEC1A CD82

2.58e-03197926729_UP
DrugRoxithromycin [80214-83-1]; Up 200; 4.8uM; PC3; HT_HG-U133A

CLEC1A CRHR2

2.58e-03197924192_UP
DrugCefotetan [69712-56-7]; Up 200; 7uM; MCF7; HT_HG-U133A

CLEC1A CRHR2

2.58e-03197924116_UP
DrugCP-320650-01 [172079-28-6]; Down 200; 1uM; PC3; HT_HG-U133A

CRHR2 CD82

2.58e-03197923825_DN
DrugNaloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A

PIGR CD82

2.58e-03197921506_UP
DrugHyoscyamine (L) [101-31-5]; Up 200; 13.8uM; PC3; HT_HG-U133A

CRHR2 CD82

2.58e-03197925099_UP
DrugCarcinine [56897-53-1]; Up 200; 22uM; MCF7; HT_HG-U133A

CRHR2 CD82

2.58e-03197923242_UP
DrugEthamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A

CLEC1A CD82

2.58e-03197922879_UP
DrugTrimethoprim [738-70-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A

CRHR2 PIGR

2.58e-03197922307_UP
DrugBetulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A

CRHR2 PIGR

2.58e-03197924181_UP
DrugRolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A

CLEC1A CRHR2

2.58e-03197926449_UP
DrugPhthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A

CRHR2 CD82

2.58e-03197925249_UP
DrugGlibenclamide [10238-21-8]; Up 200; 8uM; MCF7; HT_HG-U133A

CRHR2 PIGR

2.60e-03198923163_UP
DrugBrompheniramine maleate [980-71-2]; Up 200; 9.2uM; PC3; HT_HG-U133A

PIGR CD82

2.60e-03198924013_UP
DrugLobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A

PIGR CD82

2.60e-03198925500_UP
DrugCP-320650-01 [172079-28-6]; Down 200; 10uM; MCF7; HT_HG-U133A

CRHR2 CD82

2.60e-03198923905_DN
DrugDipyrone [5907-38-0]; Up 200; 12uM; MCF7; HT_HG-U133A

CLEC1A PIGR

2.60e-03198923929_UP
DrugOxethazaine [126-27-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A

CRHR2 CD82

2.60e-03198921484_UP
DrugQuinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A

CRHR2 CD82

2.60e-03198926267_UP
DrugLY294002; Up 200; 10uM; PC3; HG-U133A

CLEC1A PIGR

2.60e-0319892461_UP
DrugMetyrapone [54-36-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A

PIGR CD82

2.60e-03198926447_UP
DrugPrilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; MCF7; HT_HG-U133A

CLEC1A CD82

2.60e-03198923624_UP
Drug17-AAG; Down 200; 0.1uM; MCF7; HG-U133A

CLEC1A CD82

2.60e-0319892221_DN
DrugTracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A

CRHR2 CD82

2.60e-03198924964_UP
DrugNialamide [51-12-7]; Up 200; 13.4uM; PC3; HT_HG-U133A

CRHR2 PIGR

2.60e-03198923790_UP
DrugNilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A

CRHR2 CD82

2.60e-03198926481_UP
DrugPractolol [6673-35-4]; Up 200; 15uM; PC3; HT_HG-U133A

CLEC1A PIGR

2.60e-03198924603_UP
DrugTocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; PC3; HT_HG-U133A

CLEC1A CRHR2

2.60e-03198926616_UP
DrugFuraltadone hydrochloride [3759-92-0]; Up 200; 11uM; PC3; HT_HG-U133A

CRHR2 PIGR

2.60e-03198923756_UP
DrugMephenesin [59-47-2]; Up 200; 22uM; MCF7; HT_HG-U133A

PIGR CD82

2.60e-03198922304_UP
DrugAzacyclonol [115-46-8]; Down 200; 15uM; MCF7; HT_HG-U133A

ZMYM3 CD82

2.60e-03198925398_DN
DrugNafcillin sodium salt monohydrate [7177-50-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A

CRHR2 PIGR

2.60e-03198923323_UP
DrugEtomidate [33125-97-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A

CRHR2 CD82

2.60e-03198923519_UP
DrugKetotifen fumarate [34580-14-8]; Up 200; 9.4uM; MCF7; HT_HG-U133A

CLEC1A PIGR

2.63e-03199923200_UP

Protein segments in the cluster

PeptideGeneStartEntry
QVKCCGWVSFYNWTD

CD82

146

P27701
AWAIGKLYYENEQCW

CRHR2

241

Q13324
NCAVMFQGAWWYKNC

FCN2

256

Q15485
WKWHGDNCYQFYKDS

CLEC1A

141

Q8NC01
CQFCDKCYSWKKDWY

ZBTB11

796

O95625
YKCDECDKVFNWWSQ

ZNF678

181

Q5SXM1
NWSVWCYVCDNEVQY

USP16

111

Q9Y5T5
CKFSSYEKYWCKWNN

PIGR

486

P01833
YEKYWCKWNNTGCQA

PIGR

491

P01833
YGVNAWKCWVQSKYA

ZMYM3

1066

Q14202